What is it about?
Sildenafil was approved in 1998 by the Food and Drug Administration for treatment of erectile dysfunction (impotence), and then in 2005 for treatment of pulmonary hypertension. Sildenafil-dyspeptic complaints could be explained by inhibited gut motility. It was found that black tea extract (BTE) and its thearubigins (TRs) improved the sildenafil-induced delay in gastric emptying (GE) and small intestinal transit (SIT) in mice. Thus, BTE could be recommended as a reliever therapy for SLD-induced gastrointestinal dysfunction.
Featured Image
Read the Original
This page is a summary of: Black Tea Extract and its Thearubigins Relieve the Sildenafil-Induced Delayed Gut Motility in Mice: A Possible Role of Nitric Oxide, Phytotherapy Research, June 2014, Wiley,
DOI: 10.1002/ptr.5183.
You can read the full text:
Contributors
The following have contributed to this page